β¨ Miscellaneous Notices
NEW ZEALAND GAZETTE, No. 74 β 20 JULY 2017
Jadewood International Limited
I, William Henry David More, Senior Solicitor, acting under delegated authority from the Secretary to the Treasury, hereby give notice that on 13 July 2017 I first became aware that the Crown was vested under section 324 of the Companies Act 1993 (by virtue of the removal of Jadewood International Limited from the Companies Register on 14 December 2012) with the following patent:
| Number | Patent title |
|---|---|
| 523295 | Compressed wood product |
Dated at Wellington this 13th day of July 2017.
WILLIAM HENRY DAVID MORE, Senior Solicitor.
2017-go3658
20-07-2017 00:00
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Apo-Cilazapril
Active Ingredient:
Cilazapril monohydrate 1.0425mg equivalent to Cilazapril 1mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Apotex New Zealand Limited
Manufacturer:
Apotex Inc, Weston, Canada
Product:
Azelastine-PROTECT
Active Ingredient:
Azelastine hydrochloride 0.5mg/mL
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Ursapharm Arzneimittel GmbH, Saarbrucken, Germany
Product:
Droperidol Panpharma
Active Ingredient:
Droperidol 0.5mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Multichem New Zealand Limited
Manufacturer:
Rotexmedica GmbH Arzneimittelwerk, Trittau, Germany
Product:
Droperidol Panpharma
Active Ingredient:
Droperidol 2.5mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Multichem New Zealand Limited
Manufacturer:
Rotexmedica GmbH Arzneimittelwerk, Trittau, Germany
Product:
Promozio 250/100
Active Ingredients:
Atovaquone 250mg
Proguanil hydrochloride 100mg
Dosage Form:
Coated tablet
New Zealand Sponsor:
Sanofi-Aventis New Zealand Limited
Manufacturer:
Glenmark Pharmaceuticals Limited, Bardez, India
Product:
Zoledronic acid Mylan
Active Ingredient:
Zoledronic acid monohydrate 5.33mg equivalent to zolendronic acid (anhydrous) 5mg
Dosage Form:
Solution for infusion
New Zealand Sponsor:
Mylan New Zealand Limited
Manufacturer:
Mylan Laboratories Limited, Anekal, India
Dated this 17th day of July 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2017-go3660
20-07-2017 00:00
35
Next Page →
β¨ LLM interpretation of page content
π Vesting of Property under Companies Act 1993
π Trade, Customs & Industry13 July 2017
Companies Act 1993, Vesting of Property, Patent, Crown
- William Henry David More, Senior Solicitor
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare17 July 2017
Medicines Act 1981, Medicines, Distribution, Medsafe
- Chris James, Group Manager, Medsafe, Ministry of Health
NZ Gazette 2017, No 74